ARRY - Array BioPharma Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts1171111
Avg. Estimate-0.14-0.15-0.49-0.38
Low Estimate-0.22-0.23-0.56-0.85
High Estimate-0.05-0.04-0.390.15
Year Ago EPS-0.25-0.12-0.74-0.49
Revenue EstimateCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
No. of Analysts1171111
Avg. Estimate71.83M73.49M275.25M365.84M
Low Estimate57.73M57.87M261.86M288.53M
High Estimate91.79M97.11M295.92M474.36M
Year Ago Sales35.44MN/A173.77M275.25M
Sales Growth (year/est)102.70%N/A58.40%32.90%
Earnings History6/29/20189/29/201812/30/20183/30/2019
EPS Est.-0.24-0.22-0.15-0.2
EPS Actual-0.25-0.12-0.05-0.17
Difference-0.010.10.10.03
Surprise %-4.20%45.50%66.70%15.00%
EPS TrendCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.14-0.15-0.49-0.38
7 Days Ago-0.14-0.15-0.49-0.38
30 Days Ago-0.15-0.15-0.49-0.38
60 Days Ago-0.2-0.19-0.57-0.43
90 Days Ago-0.21-0.19-0.59-0.42
EPS RevisionsCurrent Qtr. (Jun 2019)Next Qtr. (Sep 2019)Current Year (2019)Next Year (2020)
Up Last 7 Days1N/A1N/A
Up Last 30 Days3526
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesARRYIndustrySectorS&P 500
Current Qtr.44.00%N/AN/A0.02
Next Qtr.-25.00%N/AN/A0.04
Current Year33.80%N/AN/A0.05
Next Year22.40%N/AN/A0.10
Next 5 Years (per annum)10.00%N/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A